Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

April 20, 2023
BioUtah News
New Published Real-World Evidence Shows KidneyIntelX™ Utility

Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple Physician Specialties KidneyIntelX individualizes clinical decisions beginning at primary care where impacts of new therapies, blood pressure strategies and timely referral can have maximal effect on outcomes and cost in patients with type 2 diabetes and chronic kidney disease LONDON […]

April 20, 2023
BioUtah News
Metrodora raises $35M to address neuroimmune disease

Originally published in Axios Pro   Instacart CEO Fidji Simo waited three years to be diagnosed with POTS, the condition that led her to cofound the Metrodora Institute, a new outpatient clinical center she’s unveiling with $35 million in corporate venture backing. Why it matters: POTS — postural orthostatic tachycardia syndrome — falls into a […]

April 20, 2023
BioUtah News
Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program SALT LAKE CITY, April 18, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a service of Intermountain Health, are now certified to offer solid tumor testing to […]

April 20, 2023
BioUtah News
Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Metrodora is the first integrated, multidisciplinary medical and research center dedicated to diagnosing and treating neuroimmune axis disorders, an under-researched disease space that impacts hundreds of millions of people Institute is building the world’s first biobank and high-density data repository focused on these conditions to inform treatment and serve as the bedrock for future research […]

April 20, 2023
BioUtah News
bioMérieux receives US FDA 510(k) clearance for the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini and will apply for CLIA-waiver

Marcy-l’Étoile (France), April 13, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the fast and accurate multiplex PCR*-based BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini. bioMérieux will immediately apply for Clinical Laboratory Improvement Amendments (CLIA) waiver for the test. The […]

April 20, 2023
BioUtah News
PEEL THERAPEUTICS DESCRIBES EXCESSIVE NETOSIS INDUCTION IN LONG COVID

Peer-reviewed study offers first description of ongoing NETosis induction in Long COVID; provides insights into pathogenesis and can serve as a surrogate marker for persistent pathology Research emphasizes need to explore neutrophil-targeted therapies in acute and chronic COVID-19 SALT LAKE CITY – April 13, 2023 – Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced research […]

April 20, 2023
BioUtah News
NEW DOMESTIC SUPPLY SOURCE TO HELP ADDRESS CRITICAL SHORTAGE OF MEDICAL RADIOISOTOPES

PROPRIETARY PLATFORM WILL BE CAPABLE OF GENERATING UP TO 12 DIFFERENT RARE ISOTOPES SIMULTANEOUSLY WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, announced its state-of-the-art facility will open in the first quarter of 2025 in West Valley City, Utah. The 170,000 square foot production […]

April 13, 2023
BioUtah News
Bench to Bedside 2023 Competition

Date & Time: April 17th, 2023 | 6:00p – 8:30p Location: Utah State Capitol Building RSVP & Agenda:  bit.ly/b2b-comp-night-2023 On April 17th, join us at the Utah State Capitol Building for the 13th annual Bench to Bedside Competition Night!  Over the course of the school year, 27 student teams from universities across have come together […]

April 13, 2023
BioUtah News
BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal […]

April 12, 2023
BioUtah News
Nelson Labs® Receives ASCA Accreditation from the U.S. FDA

Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries, announced this week that it is now an ASCA-accredited testing laboratory by the U.S. Food and Drug Administration (FDA) within the category of biocompatibility. ASCA is an accreditation structure of the FDA, wherein accreditation […]

April 12, 2023
BioUtah News
Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

In a clinical decision effectiveness study, KidneyIntelX classified more Black vs non-Black patients as high risk for progression of chronic kidney disease, resulting in increased prescription of SGLT2-inhibitor drug therapy Additional study results illustrate how KidneyIntelX is aligned with the Veteran’s Health Administration care practice guidelines for risk assessment in early-stage kidney disease and the introduction […]

April 12, 2023
BioUtah News
ARUP Laboratories Chooses Gestalt’s PathFlow® Solution for Its Strategic Digital Initiatives

SPOKANE, WASHINGTON, and SALT LAKE CITY (April 12, 2023)—Gestalt Diagnostics Inc., a leading provider of artificial intelligence (AI)-powered digital pathology solutions, and ARUP Laboratories, a national academic reference laboratory with hospital and health system clients in all 50 states, today announced that ARUP has selected Gestalt’s award-winning PathFlow® digital platform as the solution to support […]

April 12, 2023
BioUtah News
Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient care SALT LAKE CITY, April 12, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and SimonMed® Imaging, one of the largest independent outpatient medical imaging providers and physician […]

March 29, 2023
BioUtah News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies

Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies

March 23, 2023
BioUtah News
Intermountain Health Launches Culmination Bio

Intermountain Health announced the launch of Culmination Bio, a biotech company developing an exclusive, anonymized, and de-identified intelligence platform.

March 18, 2023
Policy News
Recap of 2023 E&I Summit

The 2023 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah PIVOT Center (PIVOT Center), held March 16 at the Eccles Alumni House at the University of Utah, continued its tradition of bringing together Utah’s life sciences leaders, entrepreneurs and the investor community. This year’s event […]

March 9, 2023
BioUtah News
Clene announces results of exploratory analysis in treatment of ALS

SALT LAKE CITY, March 09, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced new results from exploratory analyses including delayed time to key clinical progression events in people […]

March 9, 2023
BioUtah News
Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc. to Expand Laboratory Products and Testing Capabilities

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions® today announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular diagnostic laboratory skilled at custom qualitative and quantitative assay development, and Microarrays, Inc., a leader in customer array-based products that are used as biological research tools – gene expression arrays, reverse and forward phase protein arrays. These […]

March 9, 2023
BioUtah News
Nomi Health Launches Charitable Foundation to Expand Access to Affordable, High-Quality Healthcare

The Nomi Health Charitable Foundation will broaden the company’s philanthropic investments in healthcare equity, financial and health literacy, STEAM education and social determinants of health. “Frontline Futures Initiative” will offer tuition assistance and support to underserved individuals pursuing careers in healthcare. OREM, Utah–(BUSINESS WIRE)–Nomi Health, a direct healthcare company, has announced the creation of the […]

March 9, 2023
BioUtah News
University of Utah, TikkunLev to accelerate heart-failure gene therapy

Salt Lake City – The University of Utah, one of the nation’s leading research universities, and TikkunLev Therapeutics, a gene therapy company, have announced a new partnership to accelerate an innovative heart failure gene therapy. The agreement is an exclusive world-wide license and includes a sponsored research program to support future FDA filings. The discovery […]

March 9, 2023
BioUtah News
Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023

New instrument provides greater sensitivity to enable additional applications for discovery and characterization of novel therapeutics with unrivaled throughput and efficiency Salt Lake City, Utah —February 27, 2023—Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and […]

March 2, 2023
Policy News
BioUtah Recognizes 2023 Rare Disease Day

BioUtah on Feb. 28 joined Utah’s rare disease community, including patients, families and advocates, in recognizing 2023 Rare Disease Day at an inspirng event hosted at Recursion headquarters in Salt Lake City. Recursion CEO, Chris Gibson, along with BioHive Executive Director Aimee Edwards, kicked off the evening’s program which featured a panel of young rare […]

March 2, 2023
BioUtah News
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry SALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) — Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]

February 28, 2023
BioUtah News
BioUtah Recognizes Rare Disease Day 2023

BioUtah President and CEO, Kelvyn Cullimore, commented on Rare Disease Day held on February 28, 2023. “Today is Rare Disease Day 2023, a day being recognized in countries around the world. Here in Utah, Gov. Spencer J. Cox has declared February 28, 2023 Rare Disease Day in the state. We are marking this occasion with […]